Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Balance Sheet 2016–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1.53B | 1.50B | 1.49B | 1.55B | 1.52B | 1.76B | 1.14B | 719.6M | 490.8M | 540.6M |
| Cash & Equivalents | 421.0M | 174.0M | 214.0M | 132.9M | 307.6M | 713.5M | 433.6M | 113.4M | 100.5M | 161.1M |
| Liabilities | ||||||||||
| Total Liabilities | 1.60B | 1.24B | 1.22B | 1.19B | 599.8M | 605.2M | 481.7M | 110.7M | 107.3M | 66.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — | — | — |
| Equity | ||||||||||
| Shareholders' Equity | -80.0M | 255.0M | 275.0M | 352.0M | 922.6M | 1.15B | 653.8M | 608.9M | 383.5M | 474.0M |
Ultragenyx Pharmaceutical Inc. Balance Sheet — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) balance sheet over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RARE's balance sheet history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s balance sheet by year and by quarter, including the growth rate.